logo
Select company
Select metric
Ticker Information

Ticker

PLX

Company Name

PROTALIX BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

PROTALIX BIOTHERAPEUTICS INC - Capital Expenditures Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PLX - CapEx Coverage Historical data
DateCapital ExpenditureCapital Expenditures CoverageNet Cash Flow - Operations
6/30/2025$ 1.25M0$ -2.19M
3/31/2025$ 987K0$ -572K
12/31/2024$ 1.28M6.78$ 8.67M
9/30/2024$ 1.1M7.5$ 8.28M
6/30/2024$ 1.47M0$ -2.71M
3/31/2024$ 1.5M3.91$ 5.87M
12/31/2023$ 1.15M0$ -1.32M
9/30/2023$ 1.11M0$ -7.52M
6/30/2023$ 723K0$ -9.84M
3/31/2023$ 647K0$ -22.17M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) CapEx Coverage stands at 0.
  • Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average CapEx Coverage has been 6.06.
  • The median CapEx Coverage for PROTALIX BIOTHERAPEUTICS INC during this period was 6.78
  • PROTALIX BIOTHERAPEUTICS INC reached its highest CapEx Coverage over the past 5 years at 7.5.
  • The lowest CapEx Coverage recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 3.91

PROTALIX BIOTHERAPEUTICS INC's CapEx Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Coverage Benchmarks
CompanyCapEx Coverage
CSBR : CHAMPIONS ONCOLOGY INC 17.64THTX : THERATECHNOLOGIES INC 639.64BDTX : BLACK DIAMOND THERAPEUTICS INC -SPRO : SPERO THERAPEUTICS INC -ENTA : ENANTA PHARMACEUTICALS INC -CELU : CELULARITY INC -IVVD : INVIVYD INC -DOMH : DOMINARI HOLDINGS INC -SGMO : SANGAMO THERAPEUTICS INC -ALEC : ALECTOR INC -

Definition of Capital Expenditures Coverage

[Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: CF - Operations [ $ -22.24M ] / CapEx [ $ 408K ]
(=) CapEx Coverage [ 0 ]

PLX - Capital Expenditures Coverage, Last 5 years

3.91

Minimum

Mar 31, 2024

7.5

Maximum

Sep 30, 2024

6.06

Average

6.78

Median

CapEx Coverage Benchmark Analysis

The chart above depicts the distribution of CapEx Coverage for companies in the Total Stock Market. The average CapEx Coverage of the companies is 4.41 with a standard deviation of 4.02.
The following table provides additional summary stats:
CapEx Coverage in the Market:
filtered constituents2.21K
min0.01
max17.91
average4.41
median3.01
std4.02